Table of Contents
Thrombosis
Volume 2012 (2012), Article ID 306263, 4 pages
http://dx.doi.org/10.1155/2012/306263
Clinical Study

Evaluation of RANKL/OPG Serum Concentration Ratio as a New Biomarker for Coronary Artery Calcification: A Pilot Study

1Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9188865531, Iran
2Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad 9188865531, Iran
3Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9188865531, Iran
4Department of Cardiovascular Diseases, Razavi Hospital, 9148857114, Iran
5Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9188865531, Iran

Received 12 November 2011; Revised 20 January 2012; Accepted 24 January 2012

Academic Editor: Giovanni de Gaetano

Copyright © 2012 Amir Hooshang Mohammadpour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Amir Hooshang Mohammadpour, Jamal Shamsara, Saeed Nazemi, Samira Ghadirzadeh, Shabnam Shahsavand, and Mohammad Ramezani, “Evaluation of RANKL/OPG Serum Concentration Ratio as a New Biomarker for Coronary Artery Calcification: A Pilot Study,” Thrombosis, vol. 2012, Article ID 306263, 4 pages, 2012. doi:10.1155/2012/306263